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Current first-line chemotherapy generally consists of cytotoxic agents. While these agents 
may initially control disease by effectively debulking tumors, the tumors invariably recur due to the 
ability of cancer stem cells (CSCs) to survive and repopulate the tumor mass. To identify potential 
molecular targets in 5-fluorouracil (5-FU) refractory colon CSCs, we developed 5-FU resistant cell 
lines over a period of a year. Here we show that 5-FU maintains colon CSCs in an undifferentiated 
state in vitro. While untreated control cells passaged in parallel progressively acquired a 
differentiated morphology comprising crypt-villus structures, cells treated with an IC50 dose or 
escalating doses of 5-FU organized in round colonies with defined edges. Cells from these 
chemoresistant colonies exhibited a high nucleus-to-cytoplasm ratio and prominent nucleoli, 
features of pluripotent stem cells. Chemoresistant cells showed a reduced proliferation rate with 
respect to their counterparts. While immunofluorescence analysis revealed chemoresistant cells 
expressed a panel of pluripotency markers, flow cytometric analysis indicated a change in CD 
antigens associated with tumorigenicity and pluripotency in chemoresistant cells as compared to 
untreated cells. These results suggest colon CSCs, while under the selective pressure of 
chemotherapy in vitro, are likely to display an adaptive plasticity resembling fate reprogramming. 
Three-dimensional growth in Matrigel revealed untreated cells were able to arrange themselves in a 
ring around a well-defined central lumen. Conversely, chemoresistant cell-derived organoids had poorly 
defined or no central lumens. While untreated cells generated fast-growing, well-
differentiated tumors, resistant cells generated slow-growing, moderately differentiated tumors in 
vivo. Finally, a large number of genes were screened in cells from both groups using Real-Time 
PCR arrays. Through this analysis, we identified molecular targets that might assist in the 
development of therapeutic strategies which will counteract the mechanisms of chemoresistance. 
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